Atlas Trials

Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia

Clinical trial NCT01158885 · TERMINATED

Trial details

NCT number
NCT01158885
Sponsor
Therapeutic Advances in Childhood Leukemia Consortium
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Minimal Residual DiseaseLeukemia, Lymphoblastic, AcuteLeukemia, Myelogenous, Acute
Start date
2010-08-01
Primary completion
2012-10-24
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.